NCT02688062 - NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Spinal Cord Injury

Interventions

BIOLOGICAL

NeuroRegen Scaffold with BMMCs transplantation

Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

PROCEDURE

Surgical intradural decompression and adhesiolysis

Patients with chronic SCI (ASIA grade A) will receive intradural decompression and adhesiolysis surgery and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

Trial Locations (1)

100101

First Affiliated Hospital of PLA General Hospital, Beijing